Joseph Torresi

Summary

Affiliation: University of Melbourne
Country: Australia

Publications

  1. ncbi request reprint Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin
    Joseph Torresi
    Victorian Infectious Diseases Service, Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia
    Antivir Ther 13:337-40. 2008
  2. doi request reprint Prevention of hepatitis C virus infection and liver cancer
    E J Lim
    Department of Gastroenterology, Austin Hospital, Heidelberg, Victoria, 3084, Australia
    Recent Results Cancer Res 193:113-33. 2014
  3. ncbi request reprint Hepatitis a and e infection in international travellers
    Joseph Torresi
    Department of Infectious Diseases, Austin Center for Infection Research, Austin Hospital, Level 7, Harold Stokes Building, 145 Studley Road, Heidelberg, Victoria, 3084, Australia
    Curr Infect Dis Rep 13:248-55. 2011
  4. doi request reprint Defining infections in international travellers through the GeoSentinel surveillance network
    Joseph Torresi
    Department of Infectious Diseases and the Department of Medicine, Austin Hospital, PO Box 5555, Heidelberg, Victoria 3084, Australia
    Nat Rev Microbiol 7:895-901. 2009
  5. doi request reprint Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
    Joseph Torresi
    Department of Infectious Diseases, Austin Hospital, Heidelberg, Victoria, Australia
    Vaccine 28:7993-8000. 2010
  6. ncbi request reprint Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy
    Joseph Torresi
    Department of Medicine RMH WH, University of Melbourne, Centre for Medical Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia
    Curr Drug Targets 5:41-56. 2004
  7. doi request reprint Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
    Joseph Torresi
    Austin Centre for Infection Research, Department of Infectious Diseases Austin Hospital, Heidelberg, Victoria 3084, Australia
    J Hepatol 54:1273-85. 2011
  8. ncbi request reprint The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus
    Joseph Torresi
    Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Parkville, Vic, Australia
    J Clin Virol 25:97-106. 2002
  9. ncbi request reprint Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene
    Joseph Torresi
    Department of Medicine RMH WH, University of Melbourne, Melbourne, Victoria 3050, Australia
    Virology 299:88-99. 2002
  10. ncbi request reprint Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy
    Joseph Torresi
    Department of Medicine RMH, University of Melbourne, Parkville, Victoria 3050, Australia
    Virology 293:305-13. 2002

Detail Information

Publications59

  1. ncbi request reprint Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin
    Joseph Torresi
    Victorian Infectious Diseases Service, Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia
    Antivir Ther 13:337-40. 2008
  2. doi request reprint Prevention of hepatitis C virus infection and liver cancer
    E J Lim
    Department of Gastroenterology, Austin Hospital, Heidelberg, Victoria, 3084, Australia
    Recent Results Cancer Res 193:113-33. 2014
    ..Preventative and therapeutic vaccines against HCV remain an area of ongoing research with good progress towards developing an effective vaccine in the future...
  3. ncbi request reprint Hepatitis a and e infection in international travellers
    Joseph Torresi
    Department of Infectious Diseases, Austin Center for Infection Research, Austin Hospital, Level 7, Harold Stokes Building, 145 Studley Road, Heidelberg, Victoria, 3084, Australia
    Curr Infect Dis Rep 13:248-55. 2011
    ..2%, although this is substantially higher in pregnant women. A vaccine for hepatitis E is not available, and therefore travellers must be made aware of preventative measures to reduce their risk of infection...
  4. doi request reprint Defining infections in international travellers through the GeoSentinel surveillance network
    Joseph Torresi
    Department of Infectious Diseases and the Department of Medicine, Austin Hospital, PO Box 5555, Heidelberg, Victoria 3084, Australia
    Nat Rev Microbiol 7:895-901. 2009
    ..This Science and Society article focuses on the valuable function served by the GeoSentinel surveillance network in defining the range of infections in travellers...
  5. doi request reprint Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials
    Joseph Torresi
    Department of Infectious Diseases, Austin Hospital, Heidelberg, Victoria, Australia
    Vaccine 28:7993-8000. 2010
    ..A single dose of JE-CV elicited rapid seroconversion in a higher proportion of vaccinees than the current vaccine with fewer reactions. The safety profile of JE-CV is good...
  6. ncbi request reprint Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy
    Joseph Torresi
    Department of Medicine RMH WH, University of Melbourne, Centre for Medical Research, Royal Melbourne Hospital, Parkville, Victoria 3050, Australia
    Curr Drug Targets 5:41-56. 2004
    ..The problems are further compounded by difficulties in growing the virus in vitro and the lack of a suitable and economical animal model...
  7. doi request reprint Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
    Joseph Torresi
    Austin Centre for Infection Research, Department of Infectious Diseases Austin Hospital, Heidelberg, Victoria 3084, Australia
    J Hepatol 54:1273-85. 2011
    ..This paper will review the vaccines strategies employed, their success to date and future directions of vaccine design...
  8. ncbi request reprint The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus
    Joseph Torresi
    Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Parkville, Vic, Australia
    J Clin Virol 25:97-106. 2002
    ..The ability to change a viral protein by mutations in an overlapping but unrelated viral gene may produce HBV mutants with altered antigenicity and/or replication and a natural history that may be distinctly different to wild type HBV...
  9. ncbi request reprint Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene
    Joseph Torresi
    Department of Medicine RMH WH, University of Melbourne, Melbourne, Victoria 3050, Australia
    Virology 299:88-99. 2002
    ..Since these viruses carry mutations in the a determinant of HBsAg that may potentially decrease the ability of anti-HBs antibody to neutralize these viruses, these HBV mutants also have the potential to behave as vaccine escape mutants...
  10. ncbi request reprint Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy
    Joseph Torresi
    Department of Medicine RMH, University of Melbourne, Parkville, Victoria 3050, Australia
    Virology 293:305-13. 2002
    ..These findings raise the possibility of lamivudine-resistant mutants arising that possess antigenically distinct HBsAg proteins...
  11. ncbi request reprint A self-adjuvanting multiepitope immunogen that induces a broadly cross-reactive antibody to hepatitis C virus
    Joseph Torresi
    Department of Medicine and Clinical Centre for Research Excellence, Royal Melbourne Hospital, The University of Melbourne, Parkville 3050, Victoria, Australia
    Hepatology 45:911-20. 2007
    ..Antibody present in the sera of patients chronically infected with HCV genotypes 1, 2, 3, and 4 also bound to the HVR1-based polyepitope...
  12. pmc Travel-associated illness trends and clusters, 2000-2010
    Karin Leder
    Royal Melbourne Hospital, Parkville, Victoria, Australia
    Emerg Infect Dis 19:1049-73. 2013
    ..This multisite longitudinal analysis highlights the utility of sentinel surveillance of travelers for contributing information on disease activity trends and an evidence base for travel medicine recommendations...
  13. doi request reprint Low risk of Japanese encephalitis in short-term Australian travelers to Asia
    Irani Ratnam
    Victorian Infectious Disease Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    J Travel Med 20:206-8. 2013
    ..No travelers were infected with JE virus during travel, indicating a low risk of infection for short-term travelers...
  14. doi request reprint Gastrointestinal infection among international travelers globally
    Zoe Greenwood
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia
    J Travel Med 15:221-8. 2008
    ..The objective of this study was to analyze infections associated with oral ingestion of pathogens in international travelers in relation to place of exposure...
  15. ncbi request reprint Neutralizing antibodies in patients with chronic hepatitis C infection treated with (Peg)-interferon/ribavirin
    Irene Boo
    Macfarlane Burnet Institute for Medical Research and Public Health, Melbourne, Prahran, Victoria 3001, Australia
    J Clin Virol 39:288-94. 2007
    ..The role of neutralizing antibody (NAb) in determining response to antiviral therapy has not been established...
  16. doi request reprint Hepatitis B and C infection in international travelers
    Douglas F Johnson
    Department of Infectious Diseases, Austin Hospital, University of Melbourne, Heidelberg, Victoria, Australia
    J Travel Med 20:194-202. 2013
    ..Hepatitis B and C virus (HBV and HCV) cause significant morbidity and mortality worldwide. With the rise in international travel over the last three decades, many travelers are at risk of HBV and HCV infection...
  17. ncbi request reprint A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection
    Brendon Y Chua
    Department of Microbiology and Immunology, The University of Melbourne, Royal Parade, Parkville, Victoria 3010, Australia
    Vaccine 26:4866-75. 2008
    ....
  18. ncbi request reprint Failure of lamivudine to reverse hepatitis B virus-associated changes in ERK, Akt and cell cycle regulatory proteins
    Ruth Chin
    Department of Medicine, CCREID, Royal Melbourne Hospital, University of Melbourne, Australia
    Antivir Ther 13:221-30. 2008
    ..We recently reported that replication of HBV in a cell-culture system was associated with the upregulation of pERK, pAkt, pc-Myc, nuclear cyclin B1, p21(cip1) and p53 together with G2 cell cycle arrest...
  19. ncbi request reprint Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes
    Lara Grollo
    Cooperative Research Centre for Vaccine Technology, Department of Microbiology Et Immunology, The University of Melbourne, Parkville, Vic, Australia
    Antivir Ther 11:1005-14. 2006
    ..Here we describe epitopes that are recognized by antibody present in the serum of infected patients and show that such epitopes can induce neutralizing antibodies...
  20. ncbi request reprint Maturation of dendritic cells with lipopeptides that represent vaccine candidates for hepatitis C virus
    Brendon Y Chua
    Cooperative Research Centre for Vaccine Technology, Department of Microbiology and Immunology, The University of Melbourne, Victoria, Australia
    Immunol Cell Biol 81:67-72. 2003
    ....
  21. doi request reprint GeoSentinel surveillance of illness in returned travelers, 2007-2011
    Karin Leder
    Victorian Infectious Disease Service, Royal Melbourne Hospital, Monash University, Austin Hospital, Melbourne University
    Ann Intern Med 158:456-68. 2013
    ..International travel continues to increase, particularly to Asia and Africa. Clinicians are increasingly likely to be consulted for advice before travel or by ill returned travelers...
  22. pmc Hepatitis C VLPs delivered to dendritic cells by a TLR2 targeting lipopeptide results in enhanced antibody and cell-mediated responses
    Brendon Y Chua
    Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia
    PLoS ONE 7:e47492. 2012
    ....
  23. doi request reprint Dysregulation of hepatocyte cell cycle and cell viability by hepatitis B virus
    Ruth Chin
    Department of Medicine, Austin Hospital, University of Melbourne, Heidelberg, Victoria 3084, Australia
    Virus Res 147:7-16. 2010
    ..Hepatitis B virus (HBV) is associated with a significant risk of developing hepatocellular carcinoma but the effects of HBV on cell cycle regulation are not completely understood...
  24. pmc Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?
    C John Clements
    Melbourne University, Vic, Australia
    Bull World Health Organ 88:66-73. 2010
    ..This paper examines the mechanism of antiviral drug-selected changes in the portion of the viral genome that also affects the surface antigen, and explores their potential impact on current hepatitis B immunization programmes...
  25. ncbi request reprint Induction of neutralizing antibody responses to hepatitis C virus with synthetic peptide constructs incorporating both antibody and T-helper epitopes
    Joseph Torresi
    Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria, Australia
    Immunol Cell Biol 85:169-73. 2007
    ..These results demonstrate the potential of synthetic peptide-based constructs in the delivery of potential neutralizing epitopes that are present within the viral envelope of HCV...
  26. ncbi request reprint Highly reproducible transient transfections for the study of hepatitis B virus replication based on an internal GFP reporter system
    Theo Gouskos
    Department of Medicine RMH, University of Melbourne, Vic, Australia
    J Virol Methods 121:65-72. 2004
    ..The presence of an internal GFP reporter increased the efficiency of generating highly reproducible results and facilitated multiple forms of analysis from a single transfection accurately...
  27. doi request reprint The incidence of HBV and HCV infection in Australian travelers to Asia
    Douglas F Johnson
    Department of Infectious Diseases, Austin Hospital, University of Melbourne, Heidelberg, Victoria, Australia
    J Travel Med 20:203-5. 2013
    ..The incidence density in nonimmune travelers for HCV infection was calculated as 1.8 infections per 10,000 traveler-days and for HBV infection 2.19 per 10,000 traveler-days...
  28. ncbi request reprint Illness in travelers visiting friends and relatives: a review of the GeoSentinel Surveillance Network
    Karin Leder
    Victorian Infectious Diseases Service, Centre for Clinical Research Excellence, Royal Melbourne Hospital, Parkville, Victoria, 3052, Australia
    Clin Infect Dis 43:1185-93. 2006
    ..A greater proportion of immigrant VFRs presented with serious, potentially preventable travel-related illnesses than did tourist travelers...
  29. ncbi request reprint The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia
    Katherine B Gibney
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia
    Am J Trop Med Hyg 80:805-11. 2009
    ..Clinicians need to be aware of these conditions to meet the health needs of this group. Comprehensive health checks should be encouraged for new arrivals, particularly from high-risk areas...
  30. doi request reprint TCD8 response in diverse outcomes of recurrent exposure to hepatitis C virus
    Mandvi Bharadwaj
    Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
    Immunol Cell Biol 87:464-72. 2009
    ....
  31. ncbi request reprint Imported Plasmodium vivax malaria: demographic and clinical features in nonimmune travelers
    Julian H Elliott
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia
    J Travel Med 11:213-7. 2004
    ..Plasmodium vivax malaria is relatively common in travelers but there are few published data regarding the outcome of P. vivax malaria in this group...
  32. ncbi request reprint Illness in returned travelers and immigrants/refugees: the 6-year experience of two Australian infectious diseases units
    Daniel P O'Brien
    Victorian Infectious Diseases Service, Centre for Clinical Research Excellence, Royal Melbourne Hospital, Victoria, Australia
    J Travel Med 13:145-52. 2006
    ..Data comparing returned travelers and immigrants/refugees managed in a hospital setting is lacking...
  33. doi request reprint Impaired dendritic cell maturation in response to pandemic H1N109 influenza virus
    Ruth Chin
    Department of Medicine, Austin Hospital, The University of Melbourne, Heidelberg, Vic, Australia
    J Clin Virol 56:226-31. 2013
    ..Infection with pandemic A/H1N1/2009 influenza virus led to hospitalisation of patients not expected to be at risk of severe disease from seasonal influenza infection...
  34. ncbi request reprint Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient
    Theo Gouskos
    Department of Medicine RMH, University of Melbourne, Melbourne, Australia
    AIDS 18:1734-7. 2004
    ..However, a strong HBV-specific CD8 T-cell response was identified and may have resulted in the severe hepatitis...
  35. ncbi request reprint Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response
    Duangtawan Thammanichanond
    Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia
    Clin Immunol 128:329-39. 2008
    ..These findings provide an effective approach for the expansion of HCV-specific CTLs from PBMCs of HCV-infected patients and have potential for immunotherapeutic/vaccine development...
  36. doi request reprint Incidence and risk factors for acute respiratory illnesses and influenza virus infections in Australian travellers to Asia
    Irani Ratnam
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Australia
    J Clin Virol 57:54-8. 2013
    ..Respiratory infections including influenza are a common cause of acute short-term morbidity in travellers and yet the risk of these infections is poorly defined...
  37. pmc Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressants
    Eu Jin Lim
    Liver Transplant Unit, Austin Hospital, Heidelberg, Victoria 3084, Australia
    World J Gastroenterol 18:2172-9. 2012
    ..These findings suggest that modulation of apoptosis within the liver either by changing immunosuppressive therapy or the use of apoptosis inhibitors may help prevent fibrosis progression in patients with post-transplant HCV disease...
  38. ncbi request reprint Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis
    Ruth Chin
    Department of Medicine, CCREID, Royal Melbourne Hospital, University of Melbourne, Post Office, Parkville, VIC 3050, Australia
    J Hepatol 47:325-37. 2007
    ..Numerous studies have focused on the HBV X protein showing that it activates signal transduction pathways while few have investigated these changes in HBV-replicating hepatocytes...
  39. ncbi request reprint Malaria in travelers: a review of the GeoSentinel surveillance network
    Karin Leder
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Clin Infect Dis 39:1104-12. 2004
    ..Malaria is a common and important infection in travelers...
  40. doi request reprint Long-term follow-up of schistosomiasis serology post-treatment in Australian travelers and immigrants
    Michelle K Yong
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    J Travel Med 17:89-93. 2010
    ....
  41. doi request reprint Impact of swine influenza and quarantine measures on patients and households during the H1N1/09 pandemic
    Benjamin Teh
    Department of Infectious Diseases, Austin Hospital, Heidelberg, Victoria, Australia
    Scand J Infect Dis 44:289-96. 2012
    ..To assess the secondary attack rates (SAR) and impact of the 2009 H1N1 epidemic in Melbourne, Victoria, Australia, and the measures implemented to control household transmission...
  42. ncbi request reprint Immune responses in hepatitis C virus infection: the role of dendritic cells
    Nina L Fowler
    Macfarlane Burnet Institute for Medical Research and Public Health, Prahran, Victoria, Australia
    Immunol Cell Biol 81:63-6. 2003
    ..If dendritic cell immunotherapy for hepatitis C virus infection is to become a reality, the mechanism behind the defective allostimulatory capacity needs to be deciphered...
  43. doi request reprint A comparative analysis of methodological approaches used for estimating risk in travel medicine
    Karin Leder
    Victorian Infectious Diseases Service, Centre for Clinical Research Excellence, Royal Melbourne Hospital, Victoria, Australia
    J Travel Med 15:263-72. 2008
  44. doi request reprint Dengue fever and international travel
    Irani Ratnam
    The Royal Melbourne Hospital, Victorian Infectious Disease Service, Melbourne, Victoria, Australia The Nossal Institute of Global Health, The University of Melbourne, Melbourne, Victoria, Australia
    J Travel Med 20:384-93. 2013
    ..Dengue virus is also a significant cause of illness in international travelers with an increasing number of cases of dengue fever identified in travelers returning from dengue-endemic countries...
  45. pmc A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals
    Eric J Gowans
    Virology Program, Burnet Institute, G P O Box 2284, Melbourne, VIC 3001, Australia
    J Hepatol 53:599-607. 2010
    ..The aim of the study was to investigate the safety and efficacy of vaccination with autologous dendritic cells loaded with HCV-specific cytotoxic T cell epitopes...
  46. doi request reprint Development and validation of an instrument to assess the risk of developing viral infections in Australian travelers during international travel
    Irani Ratnam
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
    J Travel Med 18:262-70. 2011
    ..Our objective was to develop and validate a questionnaire to be used in a prospective study designed to estimate the risk of three viral infections in Australian travelers to Asia...
  47. doi request reprint Diagnosing swine flu: the inaccuracy of case definitions during the 2009 pandemic, an attempt at refinement, and the implications for future planning
    Andrew A Mahony
    Infectious Diseases Department, Austin Health, Melbourne, Vic, Australia
    Influenza Other Respir Viruses 7:403-9. 2013
    ..At the onset of the pandemic H1N1/09 influenza A outbreak in Australia, health authorities devised official clinical case definitions to guide testing and access to antiviral therapy...
  48. doi request reprint Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa
    Katherine B Gibney
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Clin Infect Dis 46:443-6. 2008
    ..001). Higher vitamin D levels were associated with lower probability of any M. tuberculosis infection (P=.001) and lower probability of tuberculosis or past tuberculosis (compared with latent tuberculosis infection; P=.001)...
  49. doi request reprint Two cases of Old World cutaneous leishmaniasis in Australian travelers visiting Morocco
    Andrew J Stewardson
    Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
    J Travel Med 17:278-80. 2010
    ..The patients were treated with sodium stibogluconate and fluconazole. Optimal treatment is not established, particularly in returned travelers, but identification of Leishmania species can help with the selection of appropriate therapy...
  50. ncbi request reprint Respiratory tract infections in travelers: a review of the GeoSentinel surveillance network
    Karin Leder
    Victorian Infectious Disease Service, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia
    Clin Infect Dis 36:399-406. 2003
    ..Knowledge of the respiratory tract infections that occur in specific groups of travelers allows for the development of targeted pretravel preventive strategies to high-risk groups...
  51. pmc Comparison of immunoglobulin G subclass concentrations in severe community-acquired pneumonia and severe pandemic 2009 influenza A (H1N1) infection
    Claire L Gordon
    Department of Infectious Diseases, Austin Health, Melbourne, Australia
    Clin Vaccine Immunol 19:446-8. 2012
    ..008] and 2.5 versus 1.2 g/liter [P < 0.001], respectively). Low IgG2 levels may be specifically linked to severe H1N1; however, it is not clear whether this association is related to H1N1 or to other features of severity...
  52. ncbi request reprint Dengue Fever in travelers returning from southeast Asia
    Valerie Sung
    Victorian Infectious Disease Service, Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia
    J Travel Med 10:208-13. 2003
    ..Dengue fever is an important illness facing travelers from nonendemic to endemic countries...
  53. doi request reprint Crohn's disease or tuberculosis?
    Kiley W J Loh
    Department of Medicine, The Northern Hospital, Epping, Victoria, Australia
    J Travel Med 18:221-3. 2011
    ....
  54. ncbi request reprint Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam
    Nguyen L Toan
    Department of Molecular Pathology, Institute of Pathology, University Hospital of Tuebingen, Germany
    Hepatology 43:1375-84. 2006
    ..Differences in the replication-phenotype of single genotypes compared to genotype-mixtures suggest that co-infection with different HBV-genotypes is associated with altered pathogenesis and clinical outcome...
  55. ncbi request reprint Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation
    C Thomas Bock
    Department of Gastroenterology and Hepatology, Medical School of Hannover, FRG
    Gastroenterology 122:264-73. 2002
    ..However, we observed a severe clinical course of hepatitis B infection in several liver transplant recipients after the emergence of lamivudine resistance. This was associated with high viral load in the blood...
  56. ncbi request reprint Co-infection of human parvovirus B19 in Vietnamese patients with hepatitis B virus infection
    Nguyen L Toan
    Department of Molecular Pathology, Institute of Pathology, University Hospital of Tuebingen, Germany
    J Hepatol 45:361-9. 2006
    ..We examined the prevalence of B19-DNA in HBV-infected Vietnamese patients and analysed the association between co-infection and the clinical outcome of HBV-infection...
  57. pmc Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells
    Anja Duechting
    Department of Molecular Pathology, Institute for Pathology, University of Tuebingen, 72076 Tuebingen, Germany
    J Virol 82:7942-52. 2008
    ..Thus, NS1 may play a critical role in the mechanism of viral pathogenesis in B19-associated iCMP...
  58. ncbi request reprint Rabies preexposure vaccination in travelers
    Philippe Gautret
    J Travel Med 14:136; author reply 136-7. 2007